FGAM
TXMD icon

Financial Gravity Asset Management’s TherapeuticsMD TXMD Stock Holding History

Financial Gravity Asset Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$0 Buy
+1
New +$68 ﹤0.01% 661
2019
Q4 		$2K Hold
1
– – ﹤0.01% 1334
2019
Q3 		$0 Hold
1
– – ﹤0.01% 1558
2019
Q2 		$0 Hold
1
– – ﹤0.01% 1667
2019
Q1 		$0 Buy
+1
New +$265 ﹤0.01% 1549
2018
Q3 		$1K Buy
6
+3
+100% +$919 ﹤0.01% 1260
2018
Q2 		$1K Sell
3
-1
-25% -$305 ﹤0.01% 1290
2018
Q1 		$1K Buy
+4
New +$1.12K ﹤0.01% 1274

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Financial Gravity Asset Management's TXMD Position: Q4 2020 in Review

Financial Gravity Asset Management opened a new position in TherapeuticsMD (TXMD) in Q4 2020: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #661 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in TXMD as recently as Q4 2019.

Financial Gravity Asset Management first reported a position in TXMD in Q1 2018 and has held it in 8 quarters since. The position peaked at $2K in Q4 2019. 159 funds tracked by Wall St. Rank hold TXMD as of Q4 2020.

  • Financial Gravity Asset Management held 1 share of TherapeuticsMD worth $0 as of Q4 2020.
  • TherapeuticsMD was a new Financial Gravity Asset Management position in Q4 2020.
  • TherapeuticsMD made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q4 2020, its #661 holding.
  • Financial Gravity Asset Management first reported a position in TherapeuticsMD in Q1 2018 and has held it in 8 quarters since.
  • Financial Gravity Asset Management's TherapeuticsMD position peaked at $2K in Q4 2019.
  • 159 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2020.

Based on Financial Gravity Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.